Physician profile
Allison Hansen
NPI 1215775127
$614.10
in general payments reported to CMS, 2019-2025
13 companies · $597 in 2025
The $597 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $16.68 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $153.75 | 2025 | Epclusa |
| Pfizer INC. | $96.13 | 2024-2025 | |
| Indivior INC. | $68.75 | 2025 | Sublocade |
| Otsuka America Pharmaceutical, INC. | $59.56 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $50.15 | 2025 | Auvelity |
| Novo Nordisk INC | $29.61 | 2025 | Wegovy |
| Exact Sciences Corporation | $28.00 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $27.48 | 2025 | |
| Alkermes, INC. | $27.32 | 2025 | Aristada, Lybalvi |
| Hologic Sales and Service, LLC | $24.87 | 2025 | Thinprep 2000 Processor, Aptima |
| Lilly USA, LLC | $17.41 | 2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $16.53 | 2025 | Arexvy, Bexsero, Shingrix |
| Sanofi Pasteur INC. | $14.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.